Latest Everolimus Stories
The second generation drug-eluting stent Xience V performs well in patients having primary PCI for ST elevation myocardial infarction, and has a better safety profile than that of bare metal stents.
Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis.
ABBOTT PARK, Ill., Aug. 16, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the first patient in Japan has been treated with the ABSORB(TM) bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
- A poem in which the author retracts something said in an earlier poem.